ES2059212T3 - Antagonistas paf/h1 imidazopiridina. - Google Patents

Antagonistas paf/h1 imidazopiridina.

Info

Publication number
ES2059212T3
ES2059212T3 ES92902889T ES92902889T ES2059212T3 ES 2059212 T3 ES2059212 T3 ES 2059212T3 ES 92902889 T ES92902889 T ES 92902889T ES 92902889 T ES92902889 T ES 92902889T ES 2059212 T3 ES2059212 T3 ES 2059212T3
Authority
ES
Spain
Prior art keywords
imidazopyridine
paf
antagonists
ring
condensed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92902889T
Other languages
English (en)
Spanish (es)
Inventor
David Alker
Robert John Bass
Kelvin Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2059212T3 publication Critical patent/ES2059212T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
ES92902889T 1991-02-13 1992-01-24 Antagonistas paf/h1 imidazopiridina. Expired - Lifetime ES2059212T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2059212T3 true ES2059212T3 (es) 1994-11-01

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92902889T Expired - Lifetime ES2059212T3 (es) 1991-02-13 1992-01-24 Antagonistas paf/h1 imidazopiridina.

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531L (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
EP0775139A1 (en) * 1994-08-10 1997-05-28 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
AU698487B2 (en) * 1995-08-05 1998-10-29 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
DK1311269T3 (da) 2000-08-04 2012-03-26 Dmi Biosciences Inc Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
CN101932575B (zh) 2008-01-30 2013-06-12 日本脏器制药株式会社 哌啶衍生物
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
PH12014500685B1 (en) 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
JP6231484B2 (ja) * 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 鼻炎の処置
CN105101965B (zh) 2013-03-15 2021-03-09 安皮奥制药股份有限公司 用于干细胞活动化、归巢、扩增和分化的组合物及其使用方法
JP6723222B2 (ja) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 関節病態の治療
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
JPH03503889A (ja) * 1988-03-15 1991-08-29 ジー．ディー．サール　アンド　カンパニー ＰＡＦ拮抗剤としての１Ｈ／３Ｈ‐［４‐（Ｎ，Ｎ‐ジシクロアルキル／分枝アルキルカルボキサミド）‐ベンジル］イミダゾ［４，５‐ｃ］ピリジン類
JP2511550B2 (ja) * 1988-04-28 1996-06-26 シェリング・コーポレーション 融合多環式化合物、組成物、製造方法およびｐａｆ拮抗、抗ヒスタミンおよび／または抗炎症剤としてのその使用
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
AU642265B2 (en) * 1990-05-09 1993-10-14 Pfizer Inc. Imidazo (4,5-c) pyridines with PAF antagonist activity

Also Published As

Publication number Publication date
AU650322B2 (en) 1994-06-16
ATE109482T1 (de) 1994-08-15
AU1168392A (en) 1992-09-15
BR9205615A (pt) 1994-05-17
YU48238B (sh) 1997-08-22
DE69200304T2 (de) 1994-12-08
CZ280504B6 (cs) 1996-02-14
FI933531A7 (fi) 1993-08-10
PL169304B1 (pl) 1996-06-28
FI933531A0 (fi) 1993-08-10
FI933531L (fi) 1993-08-10
CS42592A3 (en) 1992-09-16
US5358953A (en) 1994-10-25
ZA921005B (en) 1993-08-12
HU9302327D0 (en) 1993-10-28
DE69200304D1 (de) 1994-09-08
HU211202A9 (en) 1995-11-28
CA2099381A1 (en) 1992-08-14
NZ241597A (en) 1993-04-28
MY108437A (en) 1996-09-30
IL100887A (en) 1996-01-19
IE920449A1 (en) 1992-08-12
JP2506541B2 (ja) 1996-06-12
IE65125B1 (en) 1995-10-04
CN1040326C (zh) 1998-10-21
YU14392A (sh) 1994-11-15
EG20085A (en) 1997-05-31
GB9102997D0 (en) 1991-03-27
NO300592B1 (no) 1997-06-23
IL100887A0 (en) 1992-11-15
TW227000B (enExample) 1994-07-21
EP0572425B1 (en) 1994-08-03
EP0572425A1 (en) 1993-12-08
HUT65947A (en) 1994-08-29
MX9200589A (es) 1992-10-01
NO932889D0 (no) 1993-08-13
WO1992014734A1 (en) 1992-09-03
KR970005302B1 (ko) 1997-04-15
DK0572425T3 (da) 1994-09-12
CN1064275A (zh) 1992-09-09
JPH06504992A (ja) 1994-06-09
RU2114845C1 (ru) 1998-07-10
NO932889L (no) 1993-08-13
CA2099381C (en) 1996-07-09

Similar Documents

Publication Publication Date Title
ES2059212T3 (es) Antagonistas paf/h1 imidazopiridina.
ES2055630T3 (es) Triazoles sustituidos y su uso como herbicidas.
ATE57946T1 (de) Schlagzaehe polyamid-formmassen.
ES2150482T3 (es) Pirazolopirimidinas como antagonistas del factor liberador de corticotropina.
GT200000069A (es) Derivados heterociclicos utiles como agentes anticancerosos.
PT824524E (pt) Compostos de pirimidina-tioalquilo e alquileter substituidos em alfa como inibidores da transcriptase reversa viral
MX9300313A (es) Antagonistas de benzopiranos y ltb4 relacionado.
ES2054740T3 (es) Pentadienamidas paf-antagonistas.
ES2101073T3 (es) Nuevos aza-androstano-derivados 17-beta-substituidos.
ES2110260T3 (es) Androstenonas.
ES2007747A6 (es) Procedimiento de preparacion de 5,6-dihidroxiindol y de su derivado alquilado en posicion 3 y compuestos intermedios.
ES2074144T3 (es) Derivados de 4-fenilmetil-1h-indol, procedimiento y compuestos intermedios de preparacion, aplicacion como medicamentos y composiciones que los contienen.
ES2063224T3 (es) Benzoxacinil-pirazoles, su produccion y su uso.
SE8406338D0 (sv) 4,5,6,7-tetrahydrotiazolo/5,4-c/-pyridinderivat
GB936782A (en) Improvements in and relating to n-heterocyclic compounds
ATE154032T1 (de) Neue d-homo-17-oxa und d-homo-17-aza- androstanderivate
DK0557876T3 (da) Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen
PH17062A (en) Cephalosporins and pharmaceutical compositions
ES2031606T3 (es) Derivados de tiofeno
ES2031551T3 (es) Ciclobuten-3,4-dionas intermedias y su utilizacion en la preparacion de antagonistas h2 de la histamina.
ES2084547B1 (es) Antagonistas benzopiranicos y relacionados de leucotrieno b4.
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
ES8203331A1 (es) Un procedimiento para la preparacion de derivados de tirosi-na.
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
JPS57142914A (en) Remedy for allergy

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 572425

Country of ref document: ES